• Exchange: OTC US
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Life Science Equipment

Prometic Life Sciences Inc

+ Add to Watchlist


1.1100 USD 0.0500 4.72%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Prometic Life Sciences Inc (PFSCF)

Open: 1.1100 Day's Range: 1.1100 - 1.1100 Volume: 800
Previous Close: 1.0600 52wk Range: 0.2947 - 1.4930 1-Yr Rtn: +266.49%

Stock Chart for PFSCF

No chart data available.
  • PFSCF:US 1.1100
  • 1D
  • 1M
  • 1Y
Interactive PFSCF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PFSCF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (CAD) (ttm) -
Est. EPS (CAD) (12/2014) -0.0100
Est. PEG Ratio -
Market Cap (M USD) 584.85
Shares Outstanding (M) 526.89
30 Day Average Volume 25,219
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PFSCF

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for PFSCF

ProMetic Life Sciences, Inc. is an international bio-pharmaceutical company. The Company, through its subsidiaries, researches, develops, manufactures and markets a variety of commercial applications from its core technology. ProMetic's applications are used in therapeutics, large-scale drug purification, chemical genomics and proteomics, drug delivery and drug development.

Pierre LaurinPresident/CEO/FounderBruce PritchardChief Financial Officer
John MoranChief Medical OfficerFrederic DumaisDir:Communications & Investor Relations
More Company Profile & Key Executives for PFSCF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil